FDA 483 - International Trading Pharm Lab Inc - September 16, 2021

An FDA inspection of International Trading Pharm Lab Inc. in Paterson, NJ, revealed significant deficiencies in their control testing laboratory. The firm failed to thoroughly investigate out-of-specification results and lacked scientifically sound test procedures for assuring drug product quality. These issues indicate a serious breakdown in quality control and data integrity within their analytical operations.